| abstract |
The present invention relates to a composition for the prevention or treatment of cell aging-related diseases containing homo-haringtonin as an active ingredient, wherein the composition containing homo-haringtonin as an active ingredient selectively selects fibroblasts and kidney tubule cells from which aging is induced. While showing the effect of killing the seroritics, aging-induced vascular endothelial cells, epithelial melanocytes, and retinal pigment epithelial cells, as it was confirmed to exhibit the senomorphic effect of restoring the function and morphology of the cells, the homoharringtonin It acts differently depending on the type of silver cells, and can effectively prevent or treat senile eye disease, tissue fibrosis disease, atherosclerosis, osteoarthritis, degenerative brain disease, chronic skin damage, obesity and diabetes caused by cell aging. It may be provided as a composition for extending the life. |